Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.630
-0.060 (-3.55%)
At close: Mar 13, 2026, 4:00 PM EDT
1.650
+0.020 (1.23%)
After-hours: Mar 13, 2026, 7:32 PM EDT
Coherus Oncology Employees
Coherus Oncology had 147 employees as of December 31, 2025. The number of employees decreased by 81 or -35.53% compared to the previous year.
Employees
147
Change
-81
Growth
-35.53%
Revenue / Employee
$286,884
Profits / Employee
$1,143,020
Market Cap
244.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 147 | -81 | -35.53% |
| Sep 30, 2025 | 158 | -77 | -32.77% |
| Jun 30, 2025 | 177 | -69 | -28.05% |
| Mar 31, 2025 | 221 | -28 | -11.24% |
| Dec 31, 2024 | 228 | -78 | -25.49% |
| Sep 30, 2024 | 235 | -64 | -21.40% |
| Jun 30, 2024 | 246 | -48 | -16.33% |
| Mar 31, 2024 | 249 | -58 | -18.89% |
| Dec 31, 2023 | 306 | -53 | -14.76% |
| Sep 30, 2023 | 299 | -77 | -20.48% |
| Jun 30, 2023 | 294 | -74 | -20.11% |
| Mar 31, 2023 | 307 | -39 | -11.27% |
| Dec 31, 2022 | 359 | 27 | 8.13% |
| Sep 30, 2022 | 376 | 42 | 12.57% |
| Jun 30, 2022 | 368 | 57 | 18.33% |
| Mar 31, 2022 | 346 | 36 | 11.61% |
| Dec 31, 2021 | 332 | 15 | 4.73% |
| Sep 30, 2021 | 334 | 28 | 9.15% |
| Jun 30, 2021 | 311 | 5 | 1.63% |
| Mar 31, 2021 | 310 | 14 | 4.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 136 |
| Alector | 103 |
| Editas Medicine | 87 |
| Rezolute | 75 |
| Orchestra BioMed Holdings | 70 |
| Cybin | 50 |
| Surrozen | 41 |
| Ovid Therapeutics | 23 |
CHRS News
- 4 days ago - Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 - GlobeNewsWire
- 18 days ago - Coherus Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 24 days ago - Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire